Mr Aleksi Johannes Leikas
Kuopio University Hospital, Kuopio (Finland)
Long-term safety and efficacy of intramyocardial adenovirus-mediated VEGF-DdNdC gene therapy: eight-year follow-up of phase 1 KAT301 study
Event: ESC Congress 2021 - The Digital Experience
Topic: Gene Therapy, Cell Therapy
Session: Basic science e-posters
ESC 365 is supported by
